rituxan.com Rituxan® (rituximab) for RA, NHL, CLL, GPA, MPA, and PV
RITUXAN® (rituximab) is indicated for the treatment of: Low-grade or follicular CD20-positive non-Hodgkin's lymphoma as a single-agent therapy in patients whose disease recurred or did not respond to initial treatment.
Keywords: rituxan, rituximab, lymphoma symptoms, lymphoma, Lymphoma Cancer
approved-ra-therapy.com Treating Moderate To Severe Rheumatoid Arthritis | Rituxan® (rituximab) RA | HCP
Healthcare professionals treating RA in patients can find information on safety or efficacy, dosing, and Rituxan® (rituximab) prescription reimbursement. INDICATION STATEMENT - Rituxan® (rituximab), in combination with methotrexate, is indicated for...
Keywords: rheumatoid arthritis symptoms, rheumatoid arthritis treatment, rituxan, rituximab, ra treatment